Clinical Trial Update: Saphnelo Use in Females of Child-bearing Potential

View source ↗

Summary

This clinical trial update indicates the use of Saphnelo (anifrolumab) in females of child-bearing potential for systemic lupus erythematosus, with the study cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SAPHNELO (ANIFROLUMAB-FNIA)

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus | Status: NOT_YET_RECRUITING